We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > carcinogens

News List

Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article PharmaSources
April 10, 2024
Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©.
After APIs, Carcinogens NDMA and NDEA Now Impacting Formulations PharmaSources/Dishui Sinan
February 03, 2020
NMPA (CDE) released on its website the Technical Guidelines for the Research of Nitrosamine Impurities in Chemical Drugs (Draft for Comment) on Jan. 10, 2020.
FDA declares 40 generics free of carcinogens as 'sartan' recalls continue fiercepharma
April 08, 2019
As recalls on blood pressure drugs continue to plague drugmakers, the FDA declared a slate of 40 generic pills safe to use.
Heart drugs free from carcinogens identified as recalls drag on europeanpharmaceuticalreview
April 08, 2019
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens…